Promethazine misuse among methadone maintenance patients and community-based injection drug users

Journal of Addiction Medicine

Volumn 7, Issue 2, 2013, Pages 96-101

  Shapiro, Brad J ^a   Lynch, Kara L ^b   Toochinda, Tab ^b   Lutnick, Alexandra ^c,d   Cheng, Helen Y ^d   Kral, Alex H ^d  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; OPIATE; PROMETHAZINE;

ADULT; AGED; ARTICLE; COMMUNITY; DRUG MISUSE; FEMALE; HEALTH SURVEY; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; UNITED STATES; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; METHADONE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREVALENCE; PROMETHAZINE; RISK FACTORS; SAN FRANCISCO; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84877945584     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e31827f9b43     Document Type: Article

References (23)

1. Antzelevitch C. Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes. Europace 2007;9(Suppl 4):iv4-iv15.
2. Banta-Green CJ, Jackson TR, Hanrahan M, et al. Recent drug abuse trends in the Seattle-King County Area. Epidemiologic Trends in Drug Abuse: Proceedings of the Community Epidemiology Work Group. Bethesda, MD: National Institute on Drug Abuse, Division of Epidemiology, Services and Prevention Research, NIH; 2004:II: 213-222.
3. Banta-Green CJ, Jackson TR, Hanrahan M, et al. Recent drug abuse trends in the Seattle-King County Area. Epidemiologic Trends in Drug Abuse: Proceedings of the Community Epidemiology Work Group. Bethesda, MD: National Institute on Drug Abuse, Division of Epidemiology, Services and Prevention Research, NIH, 2005:II: 249-277.
4. Beuger M, Tommasello A, Schwartz R, et al. , Clonidine use and abuse among methadone program applicants and patients. J Subst Abuse Treat 1998;15: 589-593.
5. Bleich A, Gelkopf M, Schmidt V, et al. , Correlates of benzodiazepine abuse in methadone maintenance treatment: a 1 year prospective study in an Israeli clinic. Addiction 1999;94: 1533-1540.
6. Clatts M, Giang le M, Goldsamt L, et al. Nonmedical use of promethazine hydrochloride among heroin injectors in Vietnam: unrecognized risks and unintended consequences. Subst Use Misuse 2010;45: 515-527.
7. DeMaria PA, Jr. , Sterling R, Weinstein SP. The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment. Am J Addict 2000;9: 145-153.
8. Foster A, Mobley E, Wang Z. Complicated pain management in a CYP450 2D6 poor metabolizer. Pain Pract 2007;7: 352-356.
9. Jo SH, Hong HK, Chong SH, et al. , H(1) antihistamine drug promethazine directly blocks hERG K(+) channel. Pharmacol Res 2009;60: 429-437.
10. Klemme R. Use of Promethazine with Codeine syrup: cough/cold epidemic or significant abuse? Tex State Board Pharmacy Newslett 2001;24.
11. Kral AH, Malekinejad M, Vaudrey J, et al. , Comparing respondent-driven sampling and targeted sampling methods of recruiting injection drug users in San Francisco. J Urban Health 2010;87: 839-850.
12. Mayet S, Gossop M, Lintzeris N, et al. , Methadone maintenance, QTc and torsade de pointes:who needs an electrocardiogram andwhat is the prevalence of QTc prolongation? Drug Alcohol Rev 2011;30: 388-396.
13. McGee JP, Jr. , Weiss WA. Promethazine, an adjunct to preoperative medication. Ann Surg 1956;144: 861-864.
14. Mendhekar DN, Sharma H, Dali JS. Case report of substance dependencewith buprenorphine andmephentermine. Indian J Psychiatry 1999;41: 160-162.
15. Page CB, Duffull SB, Whyte IM, et al. , Promethazine overdose: clinical effects, predicting delirium and the effect of charcoal. QJM 2009;102: 123-131.
16. Reccoppa L, Malcolm R, Ware M. Gabapentin abuse in inmates with prior history of cocaine dependence. Am J Addict 2004;13: 321-323.
17. Richter PA, Burk MP. The potentiation of narcotic analgesics with phenothiazines. J Foot Surg 1992;31: 378-380.
18. SAMHSA, 2011. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies.
19. Shields LB, Hunsaker Iii JC, Corey TS, et al. Methadone toxicity fatalities: a review of medical examiner cases in a large metropolitan area. J Forensic Sci 2007;52: 1389-1395.
20. Stringer J, Welsh C, Tommasello A. Methadone-associated Q-T interval prolongation and torsades de pointes. Am J Health Syst Pharm 2009;66: 825-833.
21. Tcheremissine OV. Is quetiapine a drug of abuse? Reexamining the issue of addiction. Expert Opin Drug Saf 2008;7: 739-748.
22. Watters JK, Biernacki P. Targeted population sampling: options for the study of hidden populations. Social Probl 1989;36: 416-430.
23. Zhou X, Zhang D, Wei H. A case of dependence on the combination use of sublingual buprenorphine, scopolamine, and promethazine. Addict Disord Their Treat 2008;7: 109-112.